ASH vs KALU

The Advanced Deterministic Scorecard reveals a deeply concerning financial profile with a Piotroski F-Score of just 2/9, indicating severe weakness in fundamental health. Despite a reasonable forward P/E of 13.53 and a 2.63% dividend yield, the company is plagued by a negative profit margin (-46.33%) and ROE (-34.45%), driven by a catastrophic earnings miss in Q3 2025. While the technical trend shows short-term recovery (+25.4% over 6M), long-term performance remains weak (-38.5% over 3Y), and analyst targets offer only marginal upside. Persistent earnings disappointment, lack of insider support, and deteriorating profitability undermine any value proposition.

KALU presents a stark contrast between aggressive growth and deteriorating operational health, highlighted by a weak Piotroski F-Score of 3/9. While the company exhibits strong top-line growth (21.4% YoY) and an impressive ROE of 14.34% relative to its sector, the current price of $142.67 trades at a significant premium to its Graham Number of $88.58. The bullish growth-based intrinsic value of $200.01 is countered by bearish technical trends (10/100) and negative insider sentiment. Consequently, the stock appears overextended in the short term despite strong fundamental growth metrics.